Advanced search
Publication Cover
Emerging Therapeutic Targets Volume 4, 2000 - Issue 1
Journal homepage
39
Views
22
CrossRef citations to date
0
Altmetric
Review

The identification of quality antibacterial drug discovery targets: a case study with aminoacyl-tRNA synthetases

Paul Gallant Cubist Pharmaceuticals, Inc., 24 Emily Street, Cambridge, MA 02139, USA. [email protected]
,
John Finn Cubist Pharmaceuticals, Inc., 24 Emily Street, Cambridge, MA 02139, USA. [email protected]
,
Dennis Keith Cubist Pharmaceuticals, Inc., 24 Emily Street, Cambridge, MA 02139, USA. [email protected]
&
Philip Wendler Cubist Pharmaceuticals, Inc., 24 Emily Street, Cambridge, MA 02139, USA. [email protected]
Pages 1-9 | Published online: 25 Feb 2005

Bibliography

  • GOLD HS, MOELLERING RC: Antimicrobial-drug resistance. N Engl. J. Med. (1996) 335:1445–1453.
  • ••Summary of bacteria drug-resistance mechanisms that are aninevitable consequence of the clinical use of penicillin and vancomycin.
  • RUBIN RJ, HARRINGTON CA, POON A, DIETRICH K, GREENE JA, MOIDUDDIN A: The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. (1999) 5:9–17.
  • EDMOND MB, OBER JF, DAWSON JD, WEINBAUM DL, WENZEL RP: Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin. Infect. Dis. (1996) 23:1234–1239.
  • •General discussion of factors associated with mortality determinations due to VRE bacteraemia.
  • CENTERS FOR DISEASE CONTROL AND PREVENTION: Reduced susceptibility of Staphylococcus aureus to vancomycin-Japan. Morbid. Mortal. Weekly Rep. (1997) 46:624–626.
  • CENTERS FOR DISEASE CONTROL AND PREVENTION:Staphylococcus aureus with reduced susceptibility to vancomycin-United States. Morbid. Mortal. Weekly Rep. (1997) 46:765–766.
  • SILVER LL, BOSTIAN KA: Discovery and development of new antibiotics: the problem of antibiotic resistance. Antimicrob. Agents Chemother. (1993) 37(3):377–383.
  • ••Review article discussing antibiotic resistance as a rationalefor the discovery and development of novel chemical entities.
  • BRYSKIER A: Novelties in the field of anti-infectives in 1997. Clin. Infect. Dis. (1998) 27:865–883.
  • •Discussion of antibiotic analogues new to the field of anti-infectives in 1997.
  • LABIA R, BARTHELEMY M, PEDUZZI J, MORANDI A, TIWARI K, KAZMIERCZAK A: Overcoming enzymatic resistance in bacteria: impact on future therapy. J. mt. Med. Res. (1990) 18:48D–57D.
  • GROSH WW, QUESENBERRY PJ: Recombinant human hematopoietic growth factors in the treatment of cytopenias. Gun. Immunot Immunopathol. (1992) 62:S25–S38.
  • BLATTNER FR, PLUNKETT G III, BLOCH CA et al.: Thecomplete genome sequence of Escherichia coil K-12. Science (1997) 277:1453–1462.
  • FLEISCHMANN RD, ADAMS MD, WHITE O et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science (1 9 9 5) 269:496–512.
  • MOIR DT, SHAW KJ, HARE RS, VOVIS GF: Genomics and antimicrobial drug discovery. Antimicrob. Agents Chemother. (1999) 43(3):439–446.
  • ••Description of strategies to take advantage of genomicsequence information in the drug discovery process.
  • SCHIMMEL P, TAO J, HILL J: Aminoacyl tRNA synthetases as targets for new anti-infectives. FASEB J. (1998) 12:1599–1609.
  • ••In-depth discussion of synthetases as targets for newantibiotics.
  • ERIANI G, DELARUE M, POCH O, GANGLOFF J, MORAS D: Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature (1990) 347:203–206.
  • SCHIMMEL P: Classes of aminoacyl-tRNA synthetases and the establishment of the genetic code. Trends Biochem. Sci. (1991) 16:1–3.
  • BURBAUM JJ, SCHIMMEL P: Structural relationships and the classification of aminoacyl-tRNA synthetases. J. Biol. Chem. (1991) 266:16965–16968.
  • WEBSTER TA, TSAI H, KULA M, MACKIE GA, SCHIMMEL P: Specific sequence homology and three-dimensional structure of an aminoacyl transfer RNA synthetase. Science (1984) 226:1315–1317.
  • HOUNTONDJI C, DESSEN P, BLANQUET S: Sequence similarities among the family of aminoacyl-tRNA synthetases. Biochemie (1986) 68:1071–1078.
  • LUDMERER SW, SCHIMMEL P: Gene for yeast glutamine tRNA synthetase encodes a large amino terminal extension and provides strong confirmation of the signature sequence for a group of aminoacyl tRNA synthetases. J. Biol. Chem. (1987) 262:10801–10806.
  • MORAS D: Structural and functional relationshipsbetween aminoacyl-tRNA synthetases. Trends Biochem. Sci. (1992) 17:159–164.
  • CUSACK S, BERTHET-COLOMINAS C, HARTLEIN M, NASSAR N, LEBERMAN R: A second class of synthetase structure revealed by x-ray analysis of Escherichia coli seryl-tRNA synthetase at 2.5A. Nature (1990) 347:249–255.
  • HUGHES J, MELLOWS G: Inhibition of isoleucyl-transferribonucleic acid synthetase in Escherichia coil' by pseudomonic acid. Biochem. 1 (1978) 176:305–318.
  • HUGHES J, MELLOWS G: Interaction of pseudomonicacid A with Escherichia coil B isoleucyl-tRNA synthetase. Biochem. 1 (1980) 191:209–219.
  • HUGHES J, MELLOWS G, SOUGHTON S: How does Pseudomonas fluorescens, the producing organism of the antibiotic pseudomonic acid A, avoid suicide? FEBS Lett. (1980) 122(2):322–324.
  • WERNER RG, THORPE LF, REUTER W, NIERHAUS KH: Indolmycin inhibits prokaryotic tryptophan-tRNA ligase. Eur. j Biochem. (1976) 68(1):1–3.
  • LEHNINGER AL: The amino acid building blocks of proteins. In: Biochemistry. Worth Publishers, New York, USA (1975):71–94.
  • LANDES C, PERONA JJ, BRUNIE S et al.: A structure-basedmultiple sequence alignment of all class I aminoacyl-tRNA synthetases. Biochemie (1995) 77:194–203.

Websites

  • http://www.tigr.org The Institute for Genome Research. TIGR Microbial Databases. (1999).
  • http://www.specs.net SPECS and BioSPECS by. (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.